XML 54 R40.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Summary of Significant Accounting Policies - Revenues by Major Products (Details) $ in Thousands | 12 Months Ended
--- | ---
Jun. 30, 2017 USD ($) product_line | Jun. 30, 2016 USD ($) | Jun. 30, 2015 USD ($)
Revenue from External Customer [Line Items] |  |  |
Number of product lines | product_line | 2 |  |
Revenues | $ 199,489 | $ 206,540 | $ 190,336
Revenues percentage | 100.00% | 100.00% | 100.00%
Product Concentration Risk | Sale Revenues, Gross |  |  |
Revenue from External Customer [Line Items] |  |  |
Concentration risk, percentage | 77.90% | 77.90% | 83.70%
Protandim®product line |  |  |
Revenue from External Customer [Line Items] |  |  |
Revenues | $ 130,873 | $ 128,019 | $ 120,967
Revenues percentage | 65.60% | 62.00% | 63.60%
TrueScience® product line |  |  |
Revenue from External Customer [Line Items] |  |  |
Revenues | $ 24,440 | $ 32,914 | $ 38,287
Revenues percentage | 12.30% | 15.90% | 20.10%
Other |  |  |
Revenue from External Customer [Line Items] |  |  |
Revenues | $ 44,176 | $ 45,607 | $ 31,082
Revenues percentage | 22.10% | 22.10% | 16.30%

X
- Definition Number Of Product Lines + References No definition available. + Details
Name: | lfvn_NumberOfProductLines
Namespace Prefix: | lfvn_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Revenue, Percentage + References No definition available. + Details
Name: | lfvn_RevenuePercentage
Namespace Prefix: | lfvn_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6351-108592 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13531-108611 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6404-108592 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13537-108611 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=lfvn_SaleRevenuesGrossMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=lfvn_ProtandimMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=lfvn_LifeVantageTrueScienceSkinCareRegimenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=lfvn_OtherProductLinesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |